| Autor: |
Caruselli M; Anestesia and Intensive Care Unit, Salesi Children's Hospital , Ancona, Italy., Galante D; Anesthesia and Intensive Care Unit, University Hospital , Foggia, Italy., Ficcadenti A; Pediatric Clinic Institute, Rares Diseases Center, Politecnic University of Marches , Ancona, Italy., Carboni L; Anesthesia and Intensive Care Unit, Burlo Garofolo Children's Hospital , Trieste, Italy., Franco F; Anesthetics Department, Universitiy College Hospital , London, UK., Fabrizzi B; Pediatric Clinic Institute, Oncohaematogical Unit, Politecnic University of Marches , Ancona, Italy., Amici L; Pediatric Radiology Unit, Salesi Children's Hospital , Ancona, Italy., Giretti R; Anestesia and Intensive Care Unit, Salesi Children's Hospital , Ancona, Italy., Rocchi G; Anestesia and Intensive Care Unit, Salesi Children's Hospital , Ancona, Italy., Rinaldelli G; Anestesia and Intensive Care Unit, Salesi Children's Hospital , Ancona, Italy. |
| Abstrakt: |
Progress in medical and scientific research has increased the chances of survival for young patients with congenital diseases, children who, in the past, would not have had any chance of survival. Nowadays, congenital diseases can be treated with appropriate replacement therapies. These treatments can be difficult to administer in young patients because of the high frequency of administration (sometimes more than a dose per week), the use of intravenous infusion and the long-term or life-term requirement. |
